2/14
11:48 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $50.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $50.00 price target on the stock.
2/14
11:48 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $50.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $50.00 price target on the stock.
2/14
11:37 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
1/15
09:54 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $61.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $61.00 price target on the stock.
1/15
09:54 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $61.00 price target on the stock.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $61.00 price target on the stock.
1/15
09:50 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
1/15
09:50 am
idya
Rating for IDYA
Low
Report
Rating for IDYA
1/13
09:36 am
idya
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
IDEAYA Biosciences, Inc. (NASDAQ: IDYA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
1/13
09:30 am
idya
Rating for IDYA
Low
Report
Rating for IDYA